Barclays’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,278
| Closed | -$30K | – | 4481 |
|
|
2023
Q1 | $30K | Buy |
3,278
+1,552
| +90% | +$14.2K | ﹤0.01% | 3913 |
|
|
2022
Q4 | $20K | Buy |
1,726
+1,453
| +532% | +$16.8K | ﹤0.01% | 4033 |
|
|
2022
Q3 | $6K | Sell |
273
-50
| -15% | -$1.1K | ﹤0.01% | 4352 |
|
|
2022
Q2 | $8K | Buy |
+323
| New | +$8K | ﹤0.01% | 4395 |
|
|
2021
Q3 | – | Sell |
-2,839
| Closed | -$285K | – | 4195 |
|
|
2021
Q2 | $285K | Sell |
2,839
-2,251
| -44% | -$226K | ﹤0.01% | 2745 |
|
|
2021
Q1 | $475K | Buy |
5,090
+2,924
| +135% | +$273K | ﹤0.01% | 2678 |
|
|
2020
Q4 | $179K | Buy |
+2,166
| New | +$179K | ﹤0.01% | 2745 |
|
|
2020
Q1 | – | Sell |
-2
| Closed | – | – | 3980 |
|
|
2019
Q4 | $0 | Sell |
2
-1,377
| -100% | – | ﹤0.01% | 4302 |
|
|
2019
Q3 | $19K | Buy |
+1,379
| New | +$19K | ﹤0.01% | 3851 |
|
|
2018
Q2 | – | Sell |
-223
| Closed | -$23K | – | 4436 |
|
|
2018
Q1 | $23K | Sell |
223
-545
| -71% | -$56.2K | ﹤0.01% | 3806 |
|
|
2017
Q4 | $98K | Buy |
768
+751
| +4,418% | +$95.8K | ﹤0.01% | 3018 |
|
|
2017
Q3 | $2K | Sell |
17
-174
| -91% | -$20.5K | ﹤0.01% | 3892 |
|
|
2017
Q2 | $25K | Buy |
+191
| New | +$25K | ﹤0.01% | 3211 |
|